These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35895308)

  • 1. Can calcitonin gene-related peptide (CGRP) and pentraxin-3 (PTX-3) be useful in diagnosing acute migraine attack?
    Vural S; Albayrak L
    J Recept Signal Transduct Res; 2022 Dec; 42(6):562-566. PubMed ID: 35895308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of pentraxin-3 and other inflammatory biomarkers in migraine: Association with migraine characteristics.
    Ceylan M; Bayraktutan OF; Becel S; Atis Ö; Yalcin A; Kotan D
    Cephalalgia; 2016 May; 36(6):518-25. PubMed ID: 26243757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study.
    Domínguez C; Vieites-Prado A; Pérez-Mato M; Sobrino T; Rodríguez-Osorio X; López A; Campos F; Martínez F; Castillo J; Leira R
    Headache; 2018 Jan; 58(1):78-87. PubMed ID: 29131327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonin gene-related peptide in peripheral blood as a biomarker for migraine.
    Ramón C; Cernuda-Morollón E; Pascual J
    Curr Opin Neurol; 2017 Jun; 30(3):281-286. PubMed ID: 28234796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.
    Cernuda-Morollón E; Larrosa D; Ramón C; Vega J; Martínez-Camblor P; Pascual J
    Neurology; 2013 Oct; 81(14):1191-6. PubMed ID: 23975872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal.
    Lee MJ; Lee SY; Cho S; Kang ES; Chung CS
    J Headache Pain; 2018 Jul; 19(1):53. PubMed ID: 30006780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma calcitonin gene-related peptide in diagnosing and predicting paediatric migraine.
    Fan PC; Kuo PH; Chang SH; Lee WT; Wu RM; Chiou LC
    Cephalalgia; 2009 Aug; 29(8):883-90. PubMed ID: 19236383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum CGRP, VIP, and PACAP usefulness in migraine: a case-control study in chronic migraine patients in real clinical practice.
    Pérez-Pereda S; Toriello-Suárez M; Ocejo-Vinyals G; Guiral-Foz S; Castillo-Obeso J; Montes-Gómez S; Martínez-Nieto RM; Iglesias F; González-Quintanilla V; Oterino A
    Mol Biol Rep; 2020 Sep; 47(9):7125-7138. PubMed ID: 32951099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Calcitonin Gene-Related Peptide Is Elevated in Patients With Migraine and Ophthalmoplegia.
    Takkar A; Kumar KVA; Katoch D; Singh P; Minz R; Anand S; Kathirvel S; Ravishankar K; Lal V; Caplan LR
    J Neuroophthalmol; 2023 Sep; 43(3):399-405. PubMed ID: 36255114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks.
    Ashina M; Bendtsen L; Jensen R; Schifter S; Olesen J
    Pain; 2000 May; 86(1-2):133-8. PubMed ID: 10779670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitonin gene-related peptide: a possible biomarker in migraine patients with patent foramen ovale.
    Li C; Yu Y; Li N; Yin YN; Zhang L; Xie K; Huang D
    BMC Neurol; 2024 Apr; 24(1):126. PubMed ID: 38627623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in circulating alpha-calcitonin gene-related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross-sectional study.
    Pascual-Mato M; Gárate G; González-Quintanilla V; Madera-Fernández J; Castro B; García MJ; Crespo J; Rivero M; Pascual J
    Headache; 2024; 64(7):849-858. PubMed ID: 38922858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interictal levels of calcitonin gene related peptide in gingival crevicular fluid of chronic migraine patients.
    Fekrazad R; Sardarian A; Azma K; Karami M; Borhani-Haghighi A; Gharesi-Fard B; Movahedi B
    Neurol Sci; 2018 Jul; 39(7):1217-1223. PubMed ID: 29654418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitonin gene-related peptide levels in tear fluid are elevated in migraine patients compared to healthy controls.
    Kamm K; Straube A; Ruscheweyh R
    Cephalalgia; 2019 Oct; 39(12):1535-1543. PubMed ID: 31603037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial.
    Ghorbani Z; Rafiee P; Fotouhi A; Haghighi S; Rasekh Magham R; Ahmadi ZS; Djalali M; Zareei M; Razeghi Jahromi S; Shahemi S; Mahmoudi M; Togha M
    J Headache Pain; 2020 Feb; 21(1):22. PubMed ID: 32093657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No increase of calcitonin gene-related peptide in jugular blood during migraine.
    Tvedskov JF; Lipka K; Ashina M; Iversen HK; Schifter S; Olesen J
    Ann Neurol; 2005 Oct; 58(4):561-8. PubMed ID: 16178016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CGRP and PACAP-38 play an important role in diagnosing pediatric migraine.
    Liu J; Wang G; Dan Y; Liu X
    J Headache Pain; 2022 Jun; 23(1):68. PubMed ID: 35698032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of lacosamide on calcitonin gene-related peptide serum level in episodic migraine patients: a randomized, controlled trial.
    Elgamal S; Ahmed SR; Nahas MM; Hendawy SR; Elshafei O; Zeinhom MG
    Acta Neurol Belg; 2024 Jun; 124(3):965-972. PubMed ID: 38502425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Suppressing effect of the serotonin 5HT1B/D receptor agonist rizatriptan on calcitonin gene-related peptide (CGRP) concentration in migraine attacks].
    Stepień A; Jagustyn P; Trafny EA; Widerkiewicz K
    Neurol Neurochir Pol; 2003; 37(5):1013-23. PubMed ID: 15174248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine.
    Cernuda-Morollón E; Martínez-Camblor P; Ramón C; Larrosa D; Serrano-Pertierra E; Pascual J
    Headache; 2014 Jun; 54(6):987-95. PubMed ID: 24673487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.